<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04287153</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A01278-45</org_study_id>
    <nct_id>NCT04287153</nct_id>
  </id_info>
  <brief_title>Cryotherapy and Body Slimming</brief_title>
  <acronym>Cryotherapy</acronym>
  <official_title>Evaluation of the Effectiveness of Cryotherapy in Slimming of the Abdomen and Saddlebags</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinic Cryo Esthetic</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinic Cryo Esthetic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of cryotherapy on the slimming of
      subcutaneous fat mass in the abdomen and saddlebags. Cryotherapy is a completely non-invasive
      method that induces a selective reduction of fat cells by localized and controlled cooling in
      areas such as the abdomen, flanks, inner knees, inner thighs, back and arms.

      Adipose tissue is composed of two types of tissue: white and brown adipose tissue. Studies
      have shown that exposure to cold induces an increase in the number of brown adipocytes
      (detected by PET/CT-scan) under the effect of the hormone irisin produced by the muscles. In
      addition, another study has shown that prolonged exposure to cold reduces the size of brown
      adipocytes leading to thermogenesis, suggesting that cold exposure may contribute to the
      control of obesity.

      The freezing technology of this cryotherapy unit allows the temperature of the subcutaneous
      adipose tissue to move almost instantaneously from -6°C to -10°C, gradually causing the
      reduction of subcutaneous adipose tissue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, monocentric pilot and comparative (before and after) study in simple blind
      (assessor different from the operator).

        -  The effectiveness of cryotherapy will be evaluated by the metric measurement of the
           treated areas: waist circumference, from the hips to the level of the saddlebags.

        -  Measurement of subcutaneous fat mass with iDXA scanner on treated areas

        -  Metabolic parameters from a blood test: Liver function (AST, ALT, gamma GT),
           inflammatory markers, plasmatic fatty acids, glycerol, total cholesterol, triglycerides,
           lipids, blood sugar, insulin, lactate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 17, 2017</start_date>
  <completion_date type="Actual">September 17, 2018</completion_date>
  <primary_completion_date type="Actual">April 22, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Assessment of the effectiveness and tolerance of cryotherapy in the thinning of the abdomen and saddelbags</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metric measurements of the treated areas (cm)</measure>
    <time_frame>15 days after treatment</time_frame>
    <description>The effectiveness of cryotherapy will be evaluated by the metric measurement of the treated areas: waist circumference, from the hips to the horse's breeches.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metric measurements of the treated areas (cm)</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>The effectiveness of cryotherapy will be evaluated by the metric measurement of the treated areas: waist circumference, from the hips to the horse's breeches.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>iDXA scanner measurement</measure>
    <time_frame>15 days</time_frame>
    <description>Measurement of subcutaneous fat mass in areas treated with the iDXA scanner</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>iDXA scanner measurement</measure>
    <time_frame>3 months</time_frame>
    <description>Measurement of subcutaneous fat mass in areas treated with the iDXA scanner</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic assessment</measure>
    <time_frame>15 days after treatment</time_frame>
    <description>Metabolic assessment from a blood test: Liver function: Transaminase GOT, Transaminase GPT, Gamma GT (U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic assessment</measure>
    <time_frame>15 days after treatment</time_frame>
    <description>Total cholesterol, triglycerides, HDL cholesterol (g/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic assessment</measure>
    <time_frame>15 days after treatment</time_frame>
    <description>Neopterin (nmol/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic assessment</measure>
    <time_frame>15 days after treatment</time_frame>
    <description>leptin (pg/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic assessment</measure>
    <time_frame>15 days after treatment</time_frame>
    <description>adipoleptin (mg/l)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Obesity</condition>
  <condition>Cryotherapy Effect</condition>
  <condition>Weight Loss</condition>
  <arm_group>
    <arm_group_label>Croytherapy on abdomen and saddlebags</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six (6) to 10 applicators (application area of 17 cm X 6 cm) are applied on the dorsal side (back, waist, saddlebags) for 45 minutes and then on the ventral side (belly) for 45 minutes, with adjustments according to the size of the participant. The temperature applied with the device is variable (-10°c to -7°C).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryotherapy on abdomen and saddlebags</intervention_name>
    <description>Application of variable temperature (-10°c to -7°c) on the treated areas using the cryotherapy device FG660L-006 (Beijing ADSS Development CO., Ltd)</description>
    <arm_group_label>Croytherapy on abdomen and saddlebags</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients ≥ 18 years old and non-menopausal with a BMI between 20 and 30 (20≥IMC≤30),
             with an overload of abdominal subcutaneous fat tissue and at the saddlebags

        Exclusion Criteria:

          -  - &lt; 18 years old.

          -  Pregnancy

          -  Breastfeeding

          -  Cold allergy: 2-minute ice cube test positive

          -  A waist/hip ratio indicative of a pathological fat distribution (&gt;0.8 for women, &gt;0.9
             for men)

          -  Endocrine pathologies (Cushing's disease, endocrine tumours, unbalanced frank or
             labile hypothyroidism, hirsutism and hyper-androgenism, insulin resistance and/or
             unbalanced type 2 diabetes...)

          -  Neoplasia

          -  Psychiatric pathologies with or without treatment (Antidepressants, Neuroleptics,
             Anxiolytics...), well characterized anorexia-bulimia syndromes.

          -  Established alcoholism. Daily alcohol consumption should not exceed 2 glasses of wine
             per day.

          -  Digestive pathologies (especially hepatic) and functional digestive disorders (chronic
             constipation, alternating constipation-diarrhoea, chronic abdominal pain).

          -  Weaknesses of the abdominal wall (umbilical, inguinal, crural hernias)

          -  HIV in therapy

          -  Genetic deformities and diseases

          -  Vegetarian/vegetarian diet, macrobiotic diet

          -  Spasmophilia

          -  Surgery less than 3 months old

          -  Unbalanced coronary artery disease, untreated angina
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suva Loap, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cryoesthetic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cryoesthetic</name>
      <address>
        <city>Paris</city>
        <zip>75007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Aronne LJ. Epidemiology, morbidity, and treatment of overweight and obesity. J Clin Psychiatry. 2001;62 Suppl 23:13-22. Review.</citation>
    <PMID>11603881</PMID>
  </results_reference>
  <results_reference>
    <citation>Kennedy J, Verne S, Griffith R, Falto-Aizpurua L, Nouri K. Non-invasive subcutaneous fat reduction: a review. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1679-88. doi: 10.1111/jdv.12994. Epub 2015 Feb 9. Review.</citation>
    <PMID>25664493</PMID>
  </results_reference>
  <results_reference>
    <citation>Avram MM, Harry RS. Cryolipolysis for subcutaneous fat layer reduction. Lasers Surg Med. 2009 Dec;41(10):703-8. doi: 10.1002/lsm.20864. Review. Erratum in: Lasers Surg Med. 2012 Jul;44(5):436.</citation>
    <PMID>20014262</PMID>
  </results_reference>
  <results_reference>
    <citation>Mulholland RS, Paul MD, Chalfoun C. Noninvasive body contouring with radiofrequency, ultrasound, cryolipolysis, and low-level laser therapy. Clin Plast Surg. 2011 Jul;38(3):503-20, vii-iii. doi: 10.1016/j.cps.2011.05.002. Review.</citation>
    <PMID>21824546</PMID>
  </results_reference>
  <results_reference>
    <citation>Bernstein EF. Longitudinal evaluation of cryolipolysis efficacy: two case studies. J Cosmet Dermatol. 2013 Jun;12(2):149-52. doi: 10.1111/jocd.12036.</citation>
    <PMID>23725309</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Lans AA, Wierts R, Vosselman MJ, Schrauwen P, Brans B, van Marken Lichtenbelt WD. Cold-activated brown adipose tissue in human adults: methodological issues. Am J Physiol Regul Integr Comp Physiol. 2014 Jul 15;307(2):R103-13. Review.</citation>
    <PMID>24871967</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee P, Swarbrick MM, Ho KK. Brown adipose tissue in adult humans: a metabolic renaissance. Endocr Rev. 2013 Jun;34(3):413-38. doi: 10.1210/er.2012-1081. Epub 2013 Apr 2. Review.</citation>
    <PMID>23550082</PMID>
  </results_reference>
  <results_reference>
    <citation>Manstein D, Laubach H, Watanabe K, Farinelli W, Zurakowski D, Anderson RR. Selective cryolysis: a novel method of non-invasive fat removal. Lasers Surg Med. 2008 Nov;40(9):595-604. doi: 10.1002/lsm.20719.</citation>
    <PMID>18951424</PMID>
  </results_reference>
  <results_reference>
    <citation>Zelickson B, Egbert BM, Preciado J, Allison J, Springer K, Rhoades RW, Manstein D. Cryolipolysis for noninvasive fat cell destruction: initial results from a pig model. Dermatol Surg. 2009 Oct;35(10):1462-70. doi: 10.1111/j.1524-4725.2009.01259.x. Epub 2009 Jul 13.</citation>
    <PMID>19614940</PMID>
  </results_reference>
  <results_reference>
    <citation>Coleman SR, Sachdeva K, Egbert BM, Preciado J, Allison J. Clinical efficacy of noninvasive cryolipolysis and its effects on peripheral nerves. Aesthetic Plast Surg. 2009 Jul;33(4):482-8. doi: 10.1007/s00266-008-9286-8. Epub 2009 Mar 19.</citation>
    <PMID>19296153</PMID>
  </results_reference>
  <results_reference>
    <citation>Dierickx CC, Mazer JM, Sand M, Koenig S, Arigon V. Safety, tolerance, and patient satisfaction with noninvasive cryolipolysis. Dermatol Surg. 2013 Aug;39(8):1209-16. doi: 10.1111/dsu.12238. Epub 2013 May 2.</citation>
    <PMID>23639062</PMID>
  </results_reference>
  <results_reference>
    <citation>Garibyan L, Sipprell WH 3rd, Jalian HR, Sakamoto FH, Avram M, Anderson RR. Three-dimensional volumetric quantification of fat loss following cryolipolysis. Lasers Surg Med. 2014 Feb;46(2):75-80. doi: 10.1002/lsm.22207. Epub 2013 Dec 3.</citation>
    <PMID>24535759</PMID>
  </results_reference>
  <results_reference>
    <citation>Saarelainen J, Hakulinen M, Rikkonen T, Kröger H, Tuppurainen M, Koivumaa-Honkanen H, Honkanen R, Hujo M, Jurvelin JS. Cross-Calibration of GE Healthcare Lunar Prodigy and iDXA Dual-Energy X-Ray Densitometers for Bone Mineral Measurements. J Osteoporos. 2016;2016:1424582. doi: 10.1155/2016/1424582. Epub 2016 Apr 27.</citation>
    <PMID>27239366</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 24, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>cryotherapy</keyword>
  <keyword>weight loss</keyword>
  <keyword>saddlebags</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

